| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |